Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy

NCT00001440 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

51

Enrollment

NIH

Sponsor class

Conditions

Breast Neoplasm
Neoplasm Metastasis

Interventions

PROCEDURE: Autologous T cells
DRUG: Interleukin-2

Sponsor

National Cancer Institute (NCI)